Other molecular biomarkers that are involved in the advanced level of BC progression are ERBB2/HER2 (Bolenz et al., 2010, Eissa et al., 2005), Loss of RB1 gene expression (Shariat et al., 2004),. This evidence concerns the gene ERBB2 and breast cancer.